Bank Mayapada Internasional Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Bank Mayapada Internasional Tbk. trades at Rp189 (market cap 4.87T, 402.5K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp248 (market cap 167.37B, 96.7K 24h volume). The key difference: Bank Mayapada Internasional Tbk. is far larger — about 29.1× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Bank Mayapada Internasional Tbk. is more actively traded (402.5K versus 96.7K). Which is the better fit depends on your goals.
| MAYA | OBAT | |
|---|---|---|
Market Cap | 4.87T | 167.37B |
Volume | 402.5K | 96.7K |
Lot | 4.03K | 967 |
Turnover | 75.61M | 23.82M |
Average Price | 187.86 | 246.34 |
Value | 75.61M | 23.82M |
Indicative Equilibrium Price | 189 | 248 |
Indicative Equilibrium Volume | 1 | 41 |
Trailing returns across standard periods
Latest headlines on both assets
PT. Bank Mayapada Tbk (the Company) was established based on Notarial Deed OF notary Edison Jingga, SH No 196 dated September 7, 1989 by the Notary Edison Jingga, SH., substitute for Misahardi Wilamarta, SH.By September 22, 1999 the bank increased its authorized capital from Rp 300,000,000,000 to Rp 650,000,000,000 which consits of 1,300,000,000 shares with nominal value of Rp 500 per share.
Read more on MAYA →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →